Previous studies have shown that continuous exposure throughout gestation until the juvenile period to environmentally-relevant doses of trichloroethylene (TCE) in the drinking water of MRL +/+ mice promoted adverse behavior associated with glutathione depletion in the cerebellum indicating increased sensitivity to oxidative stress. The purpose of this study was to extend our findings and further characterize the impact of TCE exposure on redox homeostasis and biomarkers of oxidative stress in the hippocampus, a brain region prone to oxidative stress. Instead of a continuous exposure, the mice were exposed to water only or two environmentally relevant doses of TCE in the drinking water postnatally from birth until 6 weeks of age. Biomarkers of plasma metabolites in the transsulfuration pathway and the transmethylation pathway of the methionine cycle were also examined. Gene expression of neurotrophins was examined to investigate a possible relationship between oxidative stress, redox imbalance and neurotrophic factor expression with TCE exposure. Our results show that hippocampi isolated from male mice exposed to TCE showed altered glutathione redox homeostasis indicating a more oxidized state. Also observed was a significant, dose dependent increase in glutathione precursors. Plasma from the TCE treated mice showed alterations in metabolites in the transsulfuration and transmethylation pathways indicating redox imbalance and altered methylation capacity. 3-Nitrotyrosine, a biomarker of protein oxidative stress, was also significantly higher in plasma and hippocampus of TCE-exposed mice compared to controls. In contrast, expression of key neurotrophic factors in the hippocampus (BDNF, NGF, and NT-3) was significantly reduced compared to controls. Our results demonstrate that low-level postnatal and early life TCE exposure modulates neurotrophin gene expression in the mouse hippocampus and may provide a mechanism for TCE-mediated neurotoxicity.
Introduction
Trichloroethylene (TCE) is a volatile organic chemical used primarily as an industrial solvent. In 2008, the EPA's Toxic Release Inventory data base reported that 3.6 million pounds of TCE was released in the United States. Although its use has declined, TCE is still a persistent soil and water contaminant. Consequently, the potential for human exposure is likely and represents a significant public health concern. One of the predominant non-cancer health effects associated with exposure to TCE is neurotoxicity (Bale et al., 2011; Chiu et al., 2006) . Acute exposure to concentrations of TCE associated with occupational exposure produces effects in the central nervous system (CNS) including deficits in sensory, cognitive, and motor function (Rasmussen et al., 1993) . Although less is known about the impact of non-occupational TCE exposure in the CNS, epidemiologic studies have shown that environmental TCE exposure (e.g., consumption of contaminated well water) was associated with higher mean scores for depression, lower intelligence scores, memory recall, and various mood disorders (Reif et al., 2003; Kilburn et al., 1993) . As far as developmental TCE exposure, children of mothers with occupational exposure to TCE had poorer visual acuity and lower composite neurobehavioral scores (Laslo-Baker et al., 2004; Till et al., 2001 ). Environmental TCE exposure has also been linked to autism and Parkinson's Disease (Gash et al., 2008; Windham et al., 2006) . The fact that TCE can be detected in the blood of approximately 10% of adults and children in the US underscores an urgent need to determine underlying mechanisms of TCE toxicity (Adgate et al., 2004; Ashley et al., 1994; Sexton et al., 2005) .
The perinatal brain is particularly vulnerable to environmental toxicants compared to the adult brain (Bayer et al., 1993; Dietert et al., 2008) . While the neurobehavioral and neurotoxic effects of TCE have been studied extensively with regard to adult-only exposure, the mechanisms whereby TCE exerts its effects in the brain are not fully understood. In addition, there is limited information with regard to developmental TCE neurotoxicity and which region of the brain may be more prone to its effects. Evidence suggests that the hippocampal region may represent a sensitive functional target for TCE's effects. The first 12 days of life in rodents is approximately comparable to the third trimester of human gestation (Clancy et al., 2007; Dobbing, 1971; Quinn, 2005) . During this period, the hippocampus undergoes a dramatic increase in size and a corresponding change in excitatory neurotransmission that underlies the maturation of synaptic plasticity by the end of the second postnatal week (Dumas, 2005) . Hippocampal neurogenesis continues to occur throughout adulthood albeit at a lesser degree as compared to early development. Studies have documented selective hippocampal damage in rodents exposed developmentally to low-level TCE orally via the drinking water (i.e., 16-32 mg/kg/day). Both combined prenatal and neonatal (Isaacson et al., 1989) and neonatal-only exposure (Isaacson et al., 1990 ) was associated with a decrease in myelinated fibers in CA1 region of the hippocampus at weaning age. In contrast, there was no reported effect of TCE treatment in other brain regions. Other studies have shown changes in neuronal plasticity in hippocampus in vitro and in vivo with TCE exposure (Ohta et al., 2001; Altmann et al., 2002) . Collectively both human and experimental research supports the hypothesis that TCE may impact the hippocampus, a dynamic and sensitive region of the brain that is involved in learning and memory.
It is not clear how TCE promotes hippocampal toxicity during developmental periods. One mechanism may involve the hippocampal region's inherent sensitivity to oxidative stress due to its higher rate of oxygen consumption and reactive oxygen species (ROS) generation compared to other brain regions such as the cerebellum (Uysal et al., 2012; Sato et al., 2010; Funke et al., 2011; Shankar, 2010) . To compensate for this vulnerability, the hippocampus has developed mechanisms to combat oxidative stress. The tripeptide glutathione (γ-Lglutamyl-L-cysteinylglycine) functions as the major intracellular antioxidant against oxidative stress and plays an important role in the detoxification of ROS in the brain (Biswas et al., 2006; Filomeni et al., 2002; Bobyn et al., 2002; Jain et al., 1991; Anderson et al., 1989; Martensson et al., 1991) . A decrease in the active reduced form of glutathione (GSH) and increase in the inactive oxidized disulfide form (GSSG) is a strong indicator of oxidative stress leaving the cell vulnerable to oxidative damage from pro-oxidant environmental exposures. Alterations in glutathione redox potential have been shown to modulate the fate of oligodendrocyte precursor cells , fetal cortical neurons, (Maffi et al., 2008) and maturing neurons (McLean et al., 2005) suggesting that altered brain redox status and increased oxidative stress could hinder neural development and promote developmental pathology.
One crucial pathway that intersects with the transsulfuration pathway leading to glutathione synthesis is the methionine cycle [(i.e., transmethylation) [for review see (Selhub, 2002) ]. The methionine cycle is important for over 100 essential cellular methylation reactions including DNA, RNA, protein, phospholipid and neurotransmitter methylation. As shown in Fig. 1 , this pathway involves the regeneration of methionine from homocysteine via the B12-dependent transfer of a methyl group from 5-methyl-tetrahydrofolate (5-CH 3 THF) by way of the methionine synthase (MS) reaction. Methionine is then converted to Sadenosylmethionine (SAM), the major methyl donor that participates in multiple cellular methylation reactions. Through the transfer of its methyl group, SAM is demethylated and converted to S-adenosylhomocysteine (SAH). The hydrolysis of SAH to homocysteine and adenosine completes the methionine cycle. Homocysteine can regenerate methionine for an additional methylation cycle by acquiring a new methyl group from 5-CH 3 THF or can be irreversibly removed from the methionine cycle by cystathionine beta synthase (CBS) which initiates the transsulfuration pathway for the synthesis of cysteine and glutathione. From a functional standpoint, deficits in transmethylation metabolites can alter DNA methylation and ultimately impact cell differentiation, gene expression, and chromatin structure, as well as impact glutathione pathway components leading to oxidative stress (Castro et al., 2003; Caudill et al., 2001; Feil, 2006; Yi et al., 2000) .
Epigenetic mechanisms including DNA methylation are increasingly being recognized as functionally important regulators of gene expression, including neurotrophic factor gene expression, in the brain. Changes in these mechanisms can lead to adverse behavior. (Lubin et al., 2011; Numata et al., 2012; Chestnut et al., 2011; Wolstenholme et al., 2011) Neurotrophic factors, including Brain Derived Neurotrophic Factor (BDNF), Nerve Growth Factor (NGF), and Neurotrophin-3 (NT-3) are classically recognized as important mediators of neural growth and plasticity. BDNF, NGF, and NT-3, act by binding to their high affinity receptors TrkA, B, and C, respectively, and activate signaling pathways. Neurotrophinreceptor complexes are internalized and transported to cell bodies where they promote neuronal survival and differentiation (Reichardt, 2006) . Increasing evidence suggests that neurotrophic factors can regulate glutathione redox status and maintain control of inflammation in the brain (Kapczinski et al., 2008; Wu et al., 2004; Sable et al., 2011) . It has been shown that developmental exposure to toluene, (Win-Shwe et al., 2010) lead, (Chao et al., 2007) and infectious agents (Pang et al., 2010) increased biomarkers of oxidative stress and neuroinflammation that were associated with decreased expression of neurotrophins in regions of the brain including the hippocampus. Along this line, NGF has been shown to upregulate glutathione synthesis in mice, (Arsenijevic et al., 2007) and antioxidant therapy increased the expression of BDNF in hippocampus Moriya et al., 2011; Liu et al., 2009) . In disorders of the CNS such as autism, oxidative stress appears inextricably linked to the loss of neurotrophic support (Sajdel-Sulkowska et al., 2009; Sajdel-Sulkowska et al., 2011a) . Collectively, these results suggest that normal functioning of the hippocampus involves a positive feedback loop between anti-oxidant processes and neurotrophic support in response to pro-oxidant exposures.
Our laboratory reported that continuous low-level TCE exposure from gestational day 0 through the juvenile period [postnatal day (PND) 42] promoted peripheral T cell activation in male, but not female mice (Blossom et al., 2007a; Blossom et al., 2008) . Also observed was a significant depletion of glutathione in the cerebella of TCE treated, but not unexposed, male mice. The purpose of the current study was to determine whether low-level early life TCE exposure affected the glutathione redox potential, related methyl metabolism, and oxidative stress in the hippocampus of mice in association with a decrease in neurotrophic gene expression. The results obtained confirm an inverse association between oxidative stress and neurotrophin expression that supports our hypothesis that TCE exposure may affect glutathione and methyl metabolism via an epigenetic modulation of neurotrophinrelated genes in the hippocampus.
Materials and Methods

Mice
Our laboratory has used the MRL+/+ strain (also known as MRL/MpJ mice) to characterize the ability of TCE to promote T cell hyperactivity and to accelerate an autoimmune response (Blossom and Doss, 2007a; Gilbert et al., 2006; Griffin et al., 2000) . MRL+/+ mice are autoimmune-prone and develop a relatively mild lupus-like disease late in life. MRL+/+ mice have been used as controls for MRL/lpr mice that develop a fulminate, early-life lupus due to a well defined genetic mutation that is absent in the MRL+/+ strain. In addition to autoimmune manifestations, MRL/lpr mice, but not MRL+/+ mice, develop several behavioral deficits and neuropathological changes with age and are considered to be a model of idiopathic neurological lupus (Ballok, 2007; Ballok, 2007; Ballok et al., 2004; Sakic et al., 2005; Ma et al., 2006) . However, recently the MRL+/+ strain has been identified as a novel model to study hippocampal neurogenesis. MRL+/+ mice apparently exhibit an enhanced response to pharmacologic agents that target neuroplasticity in the hippocampus over the response observed in C57BL/6 mice (Balu et al., 2009; Hodes et al., 2010) . Given the autoimmune prevalence, immune dysfunction observed in neurologic disorders like autism (Cabanlit et al., 2007; Comi et al., 1999; Molloy et al., 2006; Sweeten et al., 2003) , MRL +/+ were used in the current study to study TCE-induced hippocampal neurotoxicity.
As in our previous study, only male, but not female, offspring were evaluated here. The decision to exclude female offspring was based on our published evidence showing male mice were more sensitive than female mice to TCE-mediated neurologic effects (Blossom and Doss, 2007a; Blossom, et.al, 2008) . The reason for this disparity is not known, but inherent differences in glutathione related enzymes in males vs. females may account for this difference Gender sensitivity to neurologic disorders have been described and are clearly evidenced in autism, for example, where there is a 4 to 1 male to female gender bias (Charles, 2006) . Since the experimental endpoints included an examination of neurotrophic factors, the decision to use male mice only was made final based on evidence that estrogen and neurotrophin receptors can apparently co-localize leading to convergence or cross-coupling of their signaling pathways (Singh et al., 1999) .
Eight-week-old MRL+/+ breeder pairs were purchased from Jackson Laboratories (Bar Harbor, ME). The mice were acclimated to the animal facility for one week before breeding cages were established. During breeding the mice were housed in standard polycarbonate cages and provided with drinking water and food ad libitum. The pregnant mice were housed in separate cages and provided with nesting material (Ancare, Bellmore, NY) and checked twice daily for the presence of pups. The date was recorded on the day the pups were born (PND 0) and the dams were then randomly assigned to treatment groups (0, 0.01, and 0.1 mg/ml TCE). TCE (purity 99+% from Sigma, St. Louis, MO) was suspended in drinking water with 1% of the emulsifier Alkamuls EL-620 from Rhone-Poulenc (Cranbury, NJ). Mice not receiving TCE were given water with 1% Alkamuls. The dams (six per treatment group) received a freshly made solution of TCE in their drinking water every 2-3 days beginning at PND0. At PND21, the offspring were weaned and the male mice continued their exposure to water or TCE in the drinking water until PND42. All studies were approved by the Animal Care and Use Committee at the University of Arkansas for Medical Sciences.
Extraction and HPLC Quantification of Hippocampal and plasma 3-Ntrotyrosine levels, and glutathione and Cysteine Redox Status
At PND42, one randomly selected male mouse in from each of 6 litters per treatment group was selected and deeply anesthetized with Isoflurane inhalant (Fisher). The anesthetized mouse was subjected to retro-orbital bleeding and the blood placed in heparinized tubes and processed as described (Blossom and Doss, 2007a) . Mice were then sacrificed and the hippocampus was collected and flash frozen in liquid nitrogen. Samples were stored at -80°C until extraction. The methodological details for metabolite detection by HPLC have been described previously (Melnyk et al., 1999) . The analyses were performed using HPLC with a Shimadzu solvent delivery system (ESA model 580) and a reverse phase C18 column (3 um; 4.6 × 150 mm, MCM, Inc., Tokyo Japan) obtained from ESA, Inc. (Chemsford, MA). Hippocampus and plasma extracts were directly injected onto the column using Beckman Autosampler (model 507E). All metabolites were quantified using a model 5200A Coulochem II and CoulArray electrochemical detection system (ESA, Inc., Chelmsford, MA) equipped with a dual analytical cell (model 5010), a 4 channel analytical cell (model 6210) and a guard cell (model 5020). The concentrations of 3-Nitrotyrosine and metabolites in hippocampus and plasma were calculated from peak areas and standard calibration curves using HPLC software. Intracellular results are expressed as nanomoles per milligram of protein using the BCA Protein Assay Kit (Pierce, Rockford, IL). Plasma results are expressed as micromoles per liter. The percentage of oxidized glutathione is expressed in absolute glutathione equivalents and calculated as [2GSSG/(GSH + 2GSSG) (Melnyk et al., 2011) ].
Quantitative Real-time PCR
Fluorescence-based quantitative real-time PCR (qRT-PCR) was conducted using RNA isolated (using RNEasy, Qiagen, Germantown, MD) from hippocampi isolated from one randomly selected male from each litter. For each sample, complementary DNA (cDNA) was synthesized with random hexamers and 0.5 μg of total RNA using an iScript cDNA synthesis kit (Bio-Rad Laboratories, Inc., Hercules, CA). PCR primer sequences were designed using the National Center for Biotechnology Information gene databases and synthesized by IDT, Inc., Coralville, IA using PrimerQuest. All qRT-PCR reactions were carried out using iQ SYBR Green Supermix (Bio-Rad) on an Applied Biosystems Veriti Model thermocyler (American Life Technologies, Carlsbad, CA) according to manufacturer's protocols. No-template controls were included to detect primer dimer artifacts. DNA melting curve analysis was used as another control against primer-dimer formation and to ensure that contaminating DNA was not present in the RNA preparations.
C t values >36 were not reported because of implied low efficiency. The relative gene expression was calculated using the delta-delta C t method based on normalization to the reference gene Pgk1, known to be a reliable control for mouse brain regions during development, maturation, and aging (Boda et al., 2009 ) The C t value of this reference gene did not vary more than 5% among the treatment groups and was found to be superior to other reference genes (e.g., 18S ribosomal RNA) in terms of copy number and treatmentassociated invariance in the hippocampus. The results were reported as fold change in hippocampus from treated compared with expression in hippocampus from control mice.
Statistical Analysis
Statistical analysis was performed using the data analysis software, GraphPad Prism 5.0 (LaJolla, CA). All data were expressed as mean ± standard deviation (SD). One way ANOVA with a Dunnett's Multiple Comparison Test was used to determine significant differences between control vs. low or high treatment groups. Treatment related differences were considered to be significant at p<0.05.
Results
Water consumption and physical characteristics
Water consumption was measured in the dams (PND1-20) and in male mice after weaning (PND21-42). There were no statistically significant differences in water consumption among the treatment groups in the dams Fig. 2A . In the offspring, a significant decrease in water consumption was observed in both TCE-treated groups compared to controls from PND36-PND42 (Fig. 2B) . Because the TCE-treated mice exhibited normal growth and body weight as compared to controls (Fig. 3) , and no signs of dehydration (i.e., piloerection, lethargy or recessed eyes) were evident it appeared that the decreased water consumption in offspring at PND36-42 did not induce a significant functional impact.
3.1.1. Altered redox homeostasis in hippocampus of TCE exposed mice-The data presented in Table 1 shows the concentrations of glutathione (GSH), oxidized glutathione disulfide (GSSG), the glutathione redox ratio, and the percentage of oxidized glutathione equivalents in hippocampus of PND42 male mice. Compared to control mice, the GSH concentration and GSH/GSSG ratio in hippocampus of mice exposed to 0.1 mg/ml TCE was significantly decreased. Similarly, the percent oxidized glutathione was significantly increased by ~25% in the highest exposure group. Also shown are concentrations of cysteine, cystine, and the cysteine/cystine redox ratio. There was a significant dose dependent increase in cystine, the oxidized form of cysteine, with TCE exposure. Similarly, the cysteine/cystine redox ratio was significantly decreased in a dose dependent manner (~28% and ~34%; 0.01 and 0.1 mg/ml TCE, respectively). Collectively these data reveal a more oxidized environment in the hippocampus of TCEtreated mice.
Increased hippocampal
CysGly in TCE-exposed mice-CysGly is increasingly being recognized one of the major precursors of neuronal glutathione. Therefore, concentrations of this dipeptide were measured in the hippocampus. As shown in Fig. 4 , CysGly levels significantly increased with TCE treatment in a dose dependent manner; ~59% and ~74% increase with 0.01 and 0.1 mg/ml TCE, respectively over that of controls.
3.1.3. TCE exposure alters transmethylation and transsulfuration metabolites in plasma-Studies have shown abnormal plasma levels of metabolites in the transmethylation and transsulfuration pathways in humans with neurologic disorders, but it has not been possible to examine a corresponding association with abnormal redox status in the brain. Thus, plasma levels of transmethylation and transsulfuration metabolites were evaluated in order to see if the reduced anti-oxidant detoxification status observed in TCEexposed hippocampus correlated with an abnormal peripheral (i.e., plasma) metabolic profile. As shown in Table 2 , the highest concentration of TCE was associated with a significant decrease in methionine levels. Mean levels of SAM were decreased by ~39%. In contrast, SAH, a potent product inhibitor of cellular methyltransferase enzymes was significantly increased by ~38%. The dramatic decrease in the SAM/SAH ratio (~42% and 60%; at 0.01 0.1 mg/ml TCE, respectively), suggests that TCE promoted metabolic deficits in cellular methylation capacity. A corresponding TCE-mediated significant increase in homocysteine, the hydrolysis product of SAH, was also found in mice treated with the highest dose of TCE. The combined levels of precursor methionine + homocysteine were lower in TCE treated mice compared to controls indicating that the total intermediates dedicated to methylation capacity are lower in TCE-treated mice than in controls. Similarly, SAM + SAH levels were lower in TCE-treated mice than in controls.
Plasma metabolites in the transsulfuration pathway are shown in Table 3 . Both total GSH, a measure of combined protein-bound and free GSH after reduction of disulfide bonds, and free GSH which reflects unbound GSH remaining after protein precipitation were measured. Both total and free GSH were significantly lower in mice treated with TCE compared with controls. Correspondingly, both total and free GSH/GSSG ratios were also significantly lower (high TCE compared to controls). The levels of cystine were significantly increased by ~59% and ~76%; 0.01 mg/ml and 0.1 mg/ml TCE, respectively compared to controls. Total cysteine and the cysteine/cystine redox ratio were significantly decreased in TCEtreated groups. Taken together these data reflect impaired redox and methylation status in the plasma and reflect significant alterations in the transsulfuration pathway metabolites in the hippocampus.
3.1.4. TCE exposure enhances a biomarker of protein reactive nitrogen species in the hippocampus and plasma-Tyrosine nitration is a common protein modification that occurs in disease associated with oxidative stress (Andreazza et al., 2009 ).
To determine whether or not impaired intracellular anti-oxidant capacity and methylation potential was associated with protein oxidative damage, the level of 3-Nitrotyrosine was measured in the plasma and hippocampus. 3-Nitrotyrosine concentrations were increased in a dose-dependent manner in both hippocampus (Fig 5A) and plasma (Fig. 5B) indicating increased oxidative stress and protein damage in mice exposed to 0.1 mg/ml TCE.
TCE exposure downregulates the expression of neurotrophic factors in
hippocampus-Expression of three major neurotrophins, BDNF, NGF, and NT-3 were evaluated in hippocampus of control and TCE-exposed mice by real time qRT-PCR. There was a statistically significant dose-dependent downregulation in the expression of BDNF, NGF and NT-3 mRNA in hippocampus of TCE exposed mice as compared with controls (Fig. 6) . These data suggest a mechanistic link between increased oxidative stress and decreased neurotrophin expression in the brain and may be functionally important in certain neurologic disorders.
Discussion
Our laboratory has previously shown that continuous TCE exposure (i.e., gestation until PND 42) altered glutathione redox status in the cerebellum (Blossom, et.al., 2008) . In the present study, we switched our focus to the hippocampal region which is more prone to oxidative stress than other brain regions. The study employed two different doses of TCE and an exposure period of 42 days (postnatal day 1-42) that included a period of lactational exposure and direct exposure to TCE via the drinking water. Based on water intake, body weight, and measured TCE degradation in the water bottles from weaning (PND21) until sacrifice (PND42) the mice exposed to water or TCE present 0.01 or 0.1 mg/ml were directly exposed to an average of 2.0 and 28 mg/kg/day respectively. In humans the occupational exposure limit for TCE is 100 ppm or approximately 76 mg/kg/day. Thus, the concentrations of TCE used in the current study were considerably lower than the current 8-h exposure limit. Although the exposure levels used in this study are higher than the Agency for Toxic Substances and Disease Registry (ASTDR) Minimal Risk Levels (MRL) for oral exposure to TCE (0.2 mg/kg/day), the oral exposure to TCE represents only a fraction of the TCE absorbed via inhalation and dermal contact (Lee et al., 2002) Thus, since the mice were exposed to oral TCE it could be argued that the TCE exposure levels in this study are comparable to total human exposures. Water intake of the control and TCE-exposed dams was measured from PND1-PND20 (gestation and lactation). There was no significant difference in water consumption among the treatment groups. However, TCE levels in the dams were not calculated during this period. This decision was based on the concern that the handling (i.e., weighing) required to calculate mg/kg/day TCE during the lactational period would induce maternal stress and result in cannibalization of the pups or impact neurologic outcomes in the offspring as shown by others (Mueller et al., 2008; Lee et al., 2007; Ellenbroek et al., 1998) .
The goal of this study was to examine how TCE exposure affected biomarkers of methylation metabolism, oxidative stress and glutathione redox capacity, as well as neurotrophic factors associated with neuroprotection in the hippocampus of juvenile male mice. Our results clearly show that TCE exposure dose-dependently alters glutathione redox status in the brain by decreasing GSH and the GSH/GSSG ratio and increasing the percentage of GSSG. Neurons are unable to complete the transsulfuration pathway to synthesize glutathione due to insufficient quantities of cysteine, the rate limiting precursor in glutathione synthesis (Bannai, 1984) . Therefore, the extracellular redox pair, cysteine and cystine, as well as the important neuronal GSH precursor, CysGly were also evaluated in the current study. Levels of oxidized cystine were significantly elevated, and the cysteine/ cystine redox couple was significantly decreased in the hippocampus of TCE-exposed mice indicating an oxidized state. Interestingly, the CysGly GSH precursor was significantly elevated in the hippocampus of TCE-exposed mice. In the brain, CysGly is generated from glutathione released from astrocytes in the extracellular space. Although the mechanism by which CysGly is utilized by neurons is not completely understood, it is apparently hydrolyzed to cysteine and glycine and taken up into neurons via sodium-dependent transport processes to complete synthesis of neuronal glutathione. An increase in CysGly as was shown in this study could indicate that CysGly is being generated in order to compensate for TCE-mediated glutathione depletion. Alternatively, TCE may somehow inhibit the uptake or impact the exchange systems responsible for cystine or CysGly transport into cells. This mechanism could lead to glutamate toxicity, glutathione depletion, and oxidative stress. Clearly any event that interferes with glutathione homeostasis in the brain including cystine or cysteine uptake, glutathione release or utilization of CysGly or cysteine by neurons would, therefore, likely decrease neuronal glutathione levels and increase their sensitivity to oxidative stress. Such a mechanism has been demonstrated with methylmercury's ability to disrupt astrocyte transport of cystine and cysteine (Shanker et al., 2001b; Shanker et al., 2001a; Allen et al., 2001 ). Further study is needed to determine whether TCE modulates this process in astrocytic and neuronal cultures.
Consistent with our observation of altered glutathione redox status, we also observed increased 3-Nitrotyrosine levels with TCE exposure. The reaction of superoxide anion and nitric oxide to produce peroxynitrite modifies protein tyrosine residues to generate 3-nitrotyrosine. Formation of reactive nitrogen species is presumed to play a major role in neuronal cell death and the presence of 3-nitrotyrosine is presumed to be a biomarker of this event (Nakazawa et al., 2000; Butterfield et al., 2008) . This result provides additional functional evidence of a redox imbalance with TCE exposure, and also suggests that 3-nitrotyrosine levels in the plasma corresponded with brain and could potentially be an excellent candidate for a biomarker of brain oxidative stress observed in human disease. The significance of this finding is underscored by the presence of this biomarker in patients with neurologic disorders including Parkinson's disease, (Mythri et al., 2011) Alzheimer's disease (Butterfield et al., 2006) and autism (Sajdel-Sulkowska et al., 2011b) .
Plasma biomarkers of methylation capacity were evaluated in the current study due to the interrelated transsulfuration and transmethylation pathways (see Fig 1) . In an earlier study in our laboratory, a metabolomics analysis revealed a significant increase in cystathionine and decreased SAH in liver of adult mice chronically exposed to moderate levels of TCE (Gilbert et al., 2009) . The ratio of SAM: SAH is frequently used as an indicator of cellular methylation capacity whereby a decrease in this ratio as shown in our results would predict reduced methylation potential. In contrast, the effect of TCE on methylation dependent expression of neurotrophins would suggest hypermethylation. The apparent contradiction of a generalized TCE-induced hypomethylation and possible hypermethylation of specific genes in the same tissues or cells has been described. Global hypomethylation accompanied by gene-specific CpG island promoter hypermethylation has been documented in several human conditions including cancer, atherosclerosis, and aging (Dunn, 2003; Turunen et al., 2009 ).
Epigenetic mechanisms are crucial for the functional expression of neurotrophic genes (Fuchikami et al., 2011; Pittenger, 2011; Branchi et al., 2011; Roth et al., 2011) . Based on our transmethylation metabolites results in plasma, studies are planned to examine whether TCE alters the methyl metabolism and methylation status of neurotrophins in the hippocampus. Emerging evidence suggests that developmental exposure to toxicants such as polycyclic aromatic hydrocarbons and bisphenol A may promote neurodevelopmental disease via epigenetic mechanisms (Perera et al., 2011) . Studies by others have shown that exposure to methylmercury (Onishchenko et al., 2008) and ethanol (Boehme et al., 2011; Heaton et al., 2011; Kulkarny et al., 2011) modulate hippocampal BDNF in a DNA methylation dependent manner.
The effects of TCE on DNA methylation are not well defined. Low-level TCE (10 ppb) suppressed the expression of the cardiac gene Serca2a in association with hypermethylation of its promoter region (Palbykin et al., 2011) . In contrast, acute high dose TCE (1000 mg/kg/ day) decreased methylation of the promoter regions for c-jun and c-myc in the liver and a corresponding increased expression of these genes was reversed by supplemental methionine (Tao et al., 1999; Tao et al., 2000) . More recently, studies from our laboratory found that CD4 + T cells from adult mice exposed to TCE for a shorter time period (i.e., 12 weeks) demonstrated alterations in key factors associated with both DNA methylation and hypomethylation depending upon duration of exposure (Gilbert et al. in press) . Thus the effects of TCE on DNA methylation appear to be tissue-and concentration-specific and therefore difficult to generalize.
It is currently not clear how TCE impacts transsulfuration and transmethylation pathways leading to oxidative stress. One potential mechanism may involve the activity of TCE's reactive metabolite, trichloroacetaldehyde hydrate (TCAH). TCE is metabolized primarily by the cytochrome P-450s isoform CYP2E1 to a trichloroethylene oxide intermediate, which spontaneously rearranges to TCAH. TCAH is a highly reactive aldehyde that has been proposed to spontaneously condense with the biogenic amine tryptamine to produce an alkaloid-type neurotoxin (Bringmann et al., 1990) . Our lab has studied the ability of TCAH extensively to form adducts with T cells and promote their activation in vitro and in vivo (Blossom et al., 2004; Blossom et al., 2006a; Blossom et al., 2006b; Blossom et al., 2007b; Gilbert et al., 2004) The ability of reactive aldehydes (i.e., from ethanol metabolism) to inhibit methionine synthase activity and subsequently lower glutathione has been documented (Waly et al., 2011; Waly et al., 2004) . Decreased methionine synthase activity would therefore result in an accumulation of SAH and inhibition of SAM, and a depletion of GSH similar to what is observed in our model. Therefore, it is reasonable to hypothesize that TCE, via its metabolite TCAH, acts in a similar manner.
In addition to a TCE-mediated alteration of DNA methylation, metabolic intermediates for methyl metabolism can also be lowered by drawing homocysteine (and indirectly methionine via SAM and SAH) through the transsulfuration pathway to make cysteine as demonstrated in liver (Mosharov et al., 2000) , plasma (Melnyk, et.al., 2011) and in brain (Vitvitsky et al., 2006) . Cysteine can then contribute to glutathione synthesis and to antioxidant defenses. Consistent with this possibility we found lower methionine + homocysteine levels and lower SAM + SAH levels in TCE-treated mice compared to controls. This result indicated that the transsulfuration pathway converting homocysteine to cysteine is more active in TCE-treated mice than in controls and may come at the expense of methyl metabolism and methylation capacity. The TCE-induced increase in plasma homocysteine may also reflect a deficit in folate levels. Although we did not test folate levels, TCE has been shown to promote a B12 and folate deficiency in rodents (Dow et al., 2000) . Together this evidence suggests that TCE modulates DNA methylation and folate levels and future studies to examine this possibility are needed.
Our study demonstrates for the first time that the postnatal and early life period represents a sensitive window of TCE exposure by promoting a more oxidized state that is associated with decreased neurotrophin gene expression in the hippocampus. Further studies to evaluate the existence of a positive relation between alterations observed here and neurobehavior with particular relevance hippocampal function, including learning and memory, following early life postnatal TCE exposure are planned. Our results could enhance understanding of the mechanisms of neurotoxicity in susceptible human populations in order to prevent exposure and develop targeted treatments to improve neurologic function in neurodevelopmental diseases. Folate-dependent methionine transmethylation and transsulfuration pathways involved in redox potential and cellular methylation.
Fig.2. Effects of TCE on water consumption in dams and male offspring
Water consumption was monitored over time. Figure 2A presents the total volume of water (ml) the dams (n=6) consumed from PND1-PND20; Figure 2B represents the volume of water (ml/day) the male offspring consumed from weaning until sacrifice (PND21-PND42). The data is presented as mean ± SD per mouse per day. *Statistically different (p<0.05) from the results obtained from control mice (0 TCE) at PND36-42. Effects of TCE on Body Weight. Body weight was measured each week in individual male offspring each week from weaning until sacrifice. The weights of the male pups in each litter were averaged. Data points represent the mean ± SD of weights in each litter (n=6 per treatment group). CysGly levels are elevated in hippocampus of TCE-exposed mice. Metabolites in the transsulfuration pathway in hippocampus were measured by HPLC and electrochemical detection as described in the methods. Presented is nmol/mg protein of hippocampal CysGly levels in control and TCE-exposed male offspring at PND42 (n=6 per treatment group). *Statistically different from the results obtained from control mice (p <0.001). Increased oxidative stress in TCE-exposed mice. 3-Nitrotyrosine, a biomarker of oxidative stress, was measured in the hippocampus ( Figure 5A ) and plasma ( Figure 5B ) by HPLC and electrochemical detection. Presented is nmol/mg protein of 3-Nitrotyrosine levels in control and TCE-exposed male offspring at PND42 (n=6 per treatment group). *Statistically different from the results obtained from control mice (p<0.05). TCE exposure decreases neurotrophic factor gene expression in hippocampus. qRT-PCR was performed using hippocampus samples from 6 mice in each treatment group collected at PND42. *Statistically different from results obtained from control mice for each neurotrophic factor (p<0.05).
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